Association between antithrombotic therapy and risk of postoperative complications among patients undergoing endovenous laser ablation
| Autor: | Keiichi Fujino, Kazuhito Mita, Hideto Ito, Takashi Hayashi, Hideki Asakawa, Toshio Katsube, Kodai Takahashi, Masatoshi Hashimoto |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Postoperative Hemorrhage 030204 cardiovascular system & hematology Varicose Veins 03 medical and health sciences Postoperative Complications 0302 clinical medicine Fibrinolytic Agents Risk Factors Varicose veins Occlusion Antithrombotic medicine Humans Saphenous Vein 030212 general & internal medicine Vein Aged Retrospective Studies Venous Thrombosis Univariate analysis business.industry Endovascular Procedures Retrospective cohort study Perioperative medicine.disease Thrombosis Surgery medicine.anatomical_structure Case-Control Studies Female Laser Therapy Patient Safety medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of Vascular Surgery: Venous and Lymphatic Disorders. 5:339-345 |
| ISSN: | 2213-333X |
| DOI: | 10.1016/j.jvsv.2016.11.011 |
| Popis: | Background The aim of the study was to evaluate the clinical results and postoperative complications, especially recanalization or bleeding complications, in patients with saphenous varicose veins undergoing endovenous laser ablation (EVLA) while receiving antithrombotic therapy (ATT). Methods This retrospective cohort study included 1136 Japanese patients undergoing EVLA with a 980-nm diode laser between January 2012 and November 2015 at our institution. The patients were divided into two groups: ATT users (ATT group) and nonusers (control group). The ATT group was further divided into two subgroups according to whether the patients received antiplatelet or anticoagulant therapy. Clinical outcomes and postoperative complications among these patients were assessed. Results Approximately 20% of the patients undergoing surgery for saphenous varicose veins at our institution received ATT. Of these, 141 (12.4%) received antiplatelet therapy and 95 (8.4%) received anticoagulant therapy. Successful occlusion of the full length of the treated vein was achieved in 99.9% of the patients; there were no severe perioperative complications. Endovenous heat-induced thrombosis occurred in 2.4% of patients, whereas postoperative complications developed in 1.2% of patients. One patient experienced recanalization (0.08%). There were no significant between-group differences in the incidence of recanalization and postoperative complications on univariate analysis. Conclusions The clinical outcomes and postoperative complications of EVLA in the ATT group were equivalent to those in the control group, indicating that EVLA can be safely performed in patients receiving ATT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect